John P. Schmid - Mar 22, 2024 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Director
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Stock symbol
DSGN
Transactions as of
Mar 22, 2024
Transactions value $
$99,738
Form type
4
Date filed
3/25/2024, 07:10 PM
Previous filing
Mar 14, 2024
Next filing
May 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DSGN Common Stock Purchase $33.1K +9.16K $3.62 9.16K Mar 22, 2024 By Schmid Family Trust U/A dated 8-15-17 F1, F2
transaction DSGN Common Stock Purchase $66.6K +17.8K +194.51% $3.74 27K Mar 25, 2024 By Schmid Family Trust U/A dated 8-15-17
holding DSGN Common Stock 30.7K Mar 22, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $3.6187, and the range of prices were between $3.43 and $3.72. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F2 The Reporting Person is trustee of the trust.